HAGAR N.I.G.
PrivateLast Round
Series C
Aug 10, 2023
Total Funding Raised
$21.1M
Company Overview
HAGAR N.I.G. is a health technology company that develops non-invasive continuous glucose monitoring solutions using radio frequency technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HAGAR N.I.G. Comparables
Compare HAGAR N.I.G. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Afon Technology | 88% | |
| RSP Systems A/S | 86% | |
| Biolinq | 85% | |
HAGAR N.I.G. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 10, 2023 | ||||
| Series B | Aug 13, 2021 | ||||
| Series A | Jul 7, 2021 |
HAGAR N.I.G. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Columbia Pacific Advisors | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2023
Raised $5M in Series C funding.
HAGAR N.I.G. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HAGAR N.I.G.'s valuation, stock price, and market status.